No abstract available
Publication types
-
Clinical Trial, Phase II
-
Comparative Study
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
-
Decitabine / administration & dosage
-
Female
-
Follow-Up Studies
-
Humans
-
Isocitrate Dehydrogenase / genetics*
-
Kaplan-Meier Estimate
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / genetics
-
Male
-
Middle Aged
-
Mutation
-
Neoplasm Proteins / genetics*
-
Neoplasms, Second Primary / drug therapy
-
Neoplasms, Second Primary / genetics
-
Salvage Therapy
-
Sulfonamides / administration & dosage
Substances
-
Bridged Bicyclo Compounds, Heterocyclic
-
Neoplasm Proteins
-
Sulfonamides
-
Decitabine
-
IDH2 protein, human
-
Isocitrate Dehydrogenase
-
IDH1 protein, human
-
venetoclax
Associated data
-
ClinicalTrials.gov/NCT03404193